A-kinase anchor protein 75 (AKAP75) binds regulatory subunits (RIIa and RIIb) of type II protein kinase A (PKAII) isoforms and targets the resulting complexes to sites in the cytoskeleton that abut the plasma membrane [1] [2] [3] [4] [5] [6] [7] . Co-localization of AKAP75-PKAII with adenylate cyclase and PKA substrate/effector proteins in cytoskeleton and plasma membrane effects a physical and functional integration of up-stream and downstream signaling proteins, thereby ensuring efficient propagation of signals carried by locally generated cyclic AMP (cAMP) [4-9]. An important, but previously untested, prediction of the AKAP model is that efficient, cyclic nucleotide-dependent liberation of diffusible PKA catalytic subunits from cytoskeletonbound AKAP75-PKAII complexes will also enhance signaling to distal organelles, such as the nucleus. We tested this idea by using HEK-A75 cells, in which PKAII isoforms are immobilized in cortical cytoskeleton by AKAP75. Abilities of HEK-A75 and control cells (with cytoplasmically dispersed PKAII isoforms) to respond to increases in cAMP content were compared. Cells with anchored PKAII exhibited a threefold higher level of nuclear catalytic subunit content and 4-10-fold greater increments in phosphorylation of a regulatory serine residue in cAMP response element binding protein (CREB) and in phosphoCREB-stimulated transcription of the c-fos gene. Each effect occurred more rapidly in cells containing targeted AKAP75-PKAII complexes. Thus, anchoring of PKAII in actin cortical cytoskeleton increases the rate, magnitude and sensitivity of cAMP signaling to the nucleus. 
Results and discussion
The coupling of adenylate cyclase activation at the cell surface to mRNA induction involves dissociation of PKA holoenzyme, translocation of the catalytic (C) subunits to the nucleus, phosphorylation of the transcription factor CREB at Ser 133 and phosphoCREB/co-activator mediated activation of gene transcription (reviewed in [10] ). To study effects of AKAP75 on nuclear cAMP signaling, the AKAP-deficient human HEK293 cell line [11] was used as a recipient for transgenes encoding anchor proteins. Stably transfected cells that express AKAP75 or AKAP45 were created [6, 7, 11] . AKAP45, which is derived from AKAP75 by deletion of residues 1-180, binds PKAII isoforms, but lacks domains that mediate anchoring [6, 11, 12] . AKAP75 targeted and anchored >90% of RIIα and RIIβ in the cortical actin cytoskeleton that lies adjacent to the plasma membrane [6, 7] . In contrast, RII isoforms were dispersed in the cytoplasm of control cells and in cells expressing AKAP45 [6, 7, 11] .
Transcription of c-fos is activated through an upstream cAMP-responsive element (CRE) [10] . Thus, effects of anchored PKA on transcription were assessed by monitoring synthesis of c-fos mRNA. Cells were incubated in medium containing 0.1% fetal calf serum for 12 hours and were then treated with forskolin (FSK) to stimulate adenylate cyclase and 3-isobutyl-1-methylxanthine (IBMX) to inhibit cAMP phosphodiesterases. In control cells, a low level of c-fos mRNA was detected 30 minutes after activation of adenylate cyclase. The c-fos mRNA content increased over the next 60 minutes and reached a peak value 90 minutes after addition of FSK (Figure 1a,b) . Induction of c-fos mRNA by cAMP in HEK-A75 cells was more rapid and robust. A substantial amount of c-fos mRNA was detected 30 minutes after exposure to FSK (Figure 1a) . Content of c-fos mRNA peaked at 45 minutes and then declined slowly during the succeeding 45 minutes (Figure 1a,b) . Levels of c-fos mRNA were 4-10-fold higher in HEK-A75 cells than in control cells during the initial phase (0-45 minutes) of adenylate cyclase activation (Figure 1b) . By 90 minutes, c-fos transcripts were equally abundant in these cell lines. The kinetics of c-fos mRNA accumulation in HEK-A45 cells was indistinguishable from that observed in control cells. Subsequent experiments were focused on the physiologically relevant, early phase of cAMP-mediated signal transduction.
HEK-A75 cells generated 4-10-fold more c-fos mRNA than did control cells over a range of activator concentrations (Figure 1c) . To exclude the possibility that AKAP75 increased the sensitivity of adenylate cyclase to FSK, we monitored c-fos mRNA accumulation after incubating cells with 8-chlorophenylthio-cAMP (CPT-cAMP), a stable cAMP analog. CPT-cAMP selectively elicited a large increase in c-fos mRNA content in cells containing anchored PKAII (Figure 1d evaluated by assaying CREB phosphorylation at Ser 133 by western immunoblot analysis ( Figure 3 ). The level of phosphorylated CREB increased modestly in control HEK293 cells exposed to FSK. Peak phosphorylation was evident 20 minutes after addition of drug (Figure 3a) . The kinetics and extent of phosphorylation of CREB in HEK-A45 cells were similar. In HEK-A75 cells, a substantial increase in CREB phosphorylation was observed 10 minutes after adenylate cyclase activation. The concentration of phosphoCREB rose sharply for the succeeding 30 minutes. At each time point, the amount of phosphoCREB was 5-10-fold higher in HEK-A75 cells than in control cells. CREB phosphorylation was also markedly increased in HEK-A75 cells at low FSK concentrations, thereby documenting an enhanced sensitivity to cAMP in cells with anchored PKAII (Figure 3b ). Total CREB protein in nuclear extracts did not vary significantly during these experiments (Figure 3a,b) . Several stable, independently isolated lines of HEK293 and hamster AV-12 cells [7] that overexpress AKAP75, exhibit properties that are similar to those reported for HEK-A75 cells.
HEK-A75, HEK-A45 and control cells contain similar levels of PKAII isoforms [6, 7] . Synthesis and accumulation of AKAP75 (in HEK-A75 cells) elicits redistribution of holoenzyme from a large volume (cytoplasm) to a more limited 'compartment' occupied by portions of cortical actin cytoskeleton and plasma membrane [6, 7] . In accord with the AKAP model [1, 2] and laws of mass action, generation of a high concentration of PKAII in the vicinity of adenylate cyclase presumably optimizes binding of locally produced cAMP to PKAII holoenzyme, thereby facilitating dissociation of active C subunits. Initially, PKA-mediated signaling will be focused on co-localized substrates, but subsequent C subunit diffusion is also expected.
Increases in nuclear translocation of C subunits, CREB phosphorylation and c-fos mRNA synthesis in FSKtreated HEK-A75 cells suggest that anchored PKAII serves as an easily activated pool of diffusible C subunits that mediate cAMP signaling to the nucleus. Enrichment of PKAII in cortical cytoskeleton can substantially increase target cell responses to modest levels of hormones (that is, partial activation of adenylate cyclase), just as increased receptor number classically increases target cell sensitivity to low ligand concentrations. Moreover, immobilized PKAII is exposed to a maximal level of cAMP before the cyclic nucleotide is diluted and degraded (via cAMP phosphodiesterases) in cytoplasm. HEK-A45 cells, which contain unanchored AKAP-PKAII complexes, do not exhibit enhanced signaling to the nucleus. Thus, targeting and immobilization of PKAII is the key determinant of signal amplification; formation of an AKAP-PKAII complex per se is necessary, but not sufficient, for upregulation of cAMP-controlled gene transcription. In vivo fluxes in hormone concentration often occur on a timescale of seconds to several minutes. In this context, the ability of cells containing anchored PKAII to respond rapidly and with increased potency and sensitivity to modest increases in cAMP (that is, low physiological levels of hormones) confers a considerable biological advantage.
Other recent observations have linked intracellular targeting of PKAII to gene regulation. Overexpression of AKAP45 in thyroid cells causes displacement of immobilized PKAII from perinuclear sites (Golgi) to cytoplasm and depresses cAMP-controlled thyroglobulin gene expression [13] . Overexpression of AKAP75 and RII in variant PC12 cells that are defective in cAMP signal transduction restored cAMP-stimulated activation of a chimeric reporter gene [14] . In these studies, however, the exact location and composition of PKAII-anchor protein complexes were not determined; phosphorylation and activation of CREB was not addressed and data documenting positive regulation of an endogenous, cAMP-and PKA-regulated target gene (for example cfos) was lacking. Our present results show that assembly of AKAP75-PKAII complexes in cortical cytoskeleton strongly promotes CREB activation via phosphorylation at Ser 133 and a high level of expression of mRNA encoding a key transcription factor for immediate early genes, c-Fos. Regulation of AKAP75 content by hormones or developmental factors could provide a novel mechanism for regulating the sensitivity of cells to agents that activate adenylate cyclase.
Materials and methods
Cell culture, transfections, assay for c-fos mRNA, protein kinase assay, and western analysis were carried out by standard methods [6, [11] [12] [13] 15, 16] and are given in more detail in the Supplementary material published with this paper on the internet. 
